Form 4: Procter & Gamble CEO Beauty, Keith R. Alexandra, Reports Stock Option Grant
SEC Form 4
Keith R. Alexandra, CEO Beauty at Procter & Gamble, reports the acquisition of stock options and adjustments to beneficial ownership of common stock.
Summary
- On October 1, 2024, Keith R. Alexandra, CEO Beauty at Procter & Gamble, reported changes in beneficial ownership to the SEC.
- Alexandra acquired stock options to purchase 55,670 shares of common stock at a price of $173.04, exercisable from October 1, 2027, to September 29, 2034.
- His spouse acquired stock options to purchase 12,183 shares of common stock at a price of $173.04, exercisable from October 1, 2027, to September 29, 2034.
- Alexandra directly owns 17,453.1608 shares of Procter & Gamble common stock.
- He indirectly owns 4,602.8004 shares through a retirement plan trustee, 4,241.9748 shares through his spouse, and 2,493.8669 shares through his spouse's retirement plan trustee.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and suggests confidence in the executive's ability to drive future growth, but it's not a major event.
Positives
- The acquisition of stock options suggests confidence in the future performance of Procter & Gamble's stock.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It reflects part of the incentive structure for key executives like the CEO of a division.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in large, publicly traded companies like Procter & Gamble.
- Companies such as Unilever, Nestle, and L'Oreal also utilize stock options as part of their executive compensation to align management's interests with those of shareholders.
- The vesting period and exercise price are typical for such grants, designed to incentivize long-term performance.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of shareholders, incentivizing them to increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of the stock option grant and transaction. |
| 10/01/2027 | Earliest date the stock options can be exercised. |
| 09/29/2034 | Expiration date of the stock options. |
| 10/03/2024 | Date of signature on the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.